Melanoma sentinel node biopsy and prediction models for relapse and overall survival - Wikidata - awgldk - TriplyDB

Melanoma sentinel node biopsy and prediction models for relapse and overall survival

Melanoma sentinel node biopsy and prediction models for relapse and overall survival

http://www.wikidata.org/entity/Q34255928

about

Vitamin D, vitamin A, the primary melanoma transcriptome and survival Clinical and biological determinants of melanoma progression: Should all be considered for clinical management?Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research.Integrative genomics identifies gene signature associated with melanoma ulceration.The clinicopathological and gene expression patterns associated with ulceration of primary melanoma Multicenter Selective Lymphadenectomy Trial-I confirms the central role of sentinel node biopsy in contemporary melanoma management: response to 'No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisa Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort.Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma.Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database.Tumor Cell Adhesion As a Risk Factor for Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma.Validation of statistical predictive models meant to select melanoma patients for sentinel lymph node biopsy.NF‑κB inhibition is associated with OPN/MMP‑9 downregulation in cutaneous melanoma.Microenvironment and tumor progression of melanoma: new therapeutic prospectives.The role of osteopontin expression in melanoma progression.No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report.Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.Is head and neck melanoma different from trunk and extremity melanomas with respect to sentinel lymph node status and clinical outcome?Sentinel lymph node biopsy status is not the most powerful predictor of prognosis in cutaneous melanoma.Metastatic Melanoma in Sentinel Node-Negative Patients: The Ottawa Experience.The long-term prognostic impact of sentinel lymph node biopsy in patients with primary cutaneous melanoma: a prospective study with 10-year follow-up

P2860

Q28078120-0A6CC94F-8A94-44F2-AB97-CD34EACF35B1 Q30252150-DC65775E-F9F5-40E3-BB99-8941A9289E2C Q34085685-EB0926C4-4CF2-49BE-92BA-FB42CBB47A2B Q34575854-FB35AA7B-82EF-4910-81E1-5669B1A71333 Q34772146-C3EDFB93-C5C1-48A9-BAF3-837B2F2C059F Q35624171-E4264BED-A169-4E78-BADF-1C922E6006DF Q35793900-C12E34E8-40CD-49AB-81BC-FF32B2006762 Q35866890-2AFD365B-C6D6-4608-9783-83E49621047D Q36290406-CDB434E3-3E62-4A29-9013-F95E2439D30B Q37163843-C7A70984-33FD-43CA-9D90-6121297F97D1 Q37471964-0ADAD1CE-EE22-47A7-B49C-2D066EE053DB Q37707767-B521622B-12EE-475F-B478-5CF051E7136C Q38049368-4A642492-330C-4FD8-AB8B-20B1B87A55CE Q40973252-961E33A9-F0A4-4300-9DBB-9EE89A8266A4 Q41209498-174667A3-2CA1-4D58-A919-D38748528860 Q41552952-C15370D4-8890-4240-86D6-55B6250A2EF6 Q45130708-EBABE32F-D511-4F3E-897F-FF59A69C1CF8 Q47731453-F56E315E-ACB4-4880-8334-CE31F2143E1F Q50540269-E6D406C0-F23D-43E8-BBF7-BC14ACBA2234 Q58541948-160E3CC5-6D26-40D2-BD38-3808747727BF

P2860

Melanoma sentinel node biopsy and prediction models for relapse and overall survival

http://www.wikidata.org/entity/Q34255928

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Melanoma sentinel node biopsy and prediction models for relapse and overall survival

@ast

Melanoma sentinel node biopsy and prediction models for relapse and overall survival

@en

Melanoma sentinel node biopsy and prediction models for relapse and overall survival

@en-gb

Melanoma sentinel node biopsy and prediction models for relapse and overall survival

@nl

type

label

Melanoma sentinel node biopsy and prediction models for relapse and overall survival

@ast

Melanoma sentinel node biopsy and prediction models for relapse and overall survival

@en

Melanoma sentinel node biopsy and prediction models for relapse and overall survival

@en-gb

Melanoma sentinel node biopsy and prediction models for relapse and overall survival

@nl

prefLabel

Melanoma sentinel node biopsy and prediction models for relapse and overall survival

@ast

Melanoma sentinel node biopsy and prediction models for relapse and overall survival

@en

Melanoma sentinel node biopsy and prediction models for relapse and overall survival

@en-gb

Melanoma sentinel node biopsy and prediction models for relapse and overall survival

@nl

P1433

Q34255928-9F7957C1-9160-400C-B512-A4D433BE89BF

P1476

Q34255928-29E38AC0-A0E2-48AF-8237-143A1C88ADCB

P2093

Q34255928-1509C086-ECA6-462F-AC27-A0C823490ED3

Q34255928-250A18FD-5427-4337-8F5B-FD435ADA2371

Q34255928-2E1F40C6-CD1E-495B-B535-A8152BCD8BF4

Q34255928-2F5A91FF-B3A9-49F2-8287-AE1E88379C63

Q34255928-327F0F2A-B38E-48C5-A033-44147080310D

Q34255928-3B22C88A-97DF-4E4E-93A7-8C2187D3BF82

Q34255928-440283FC-44B8-40AE-9D6D-D74B67BBB1A7

Q34255928-6A99F32E-D050-42F7-8505-38AAECB60177

Q34255928-7A374DF8-294A-4E75-9222-DAE32BCE7B2E

Q34255928-894F16FF-8609-4345-A70F-5BC8FBBA5EE3

P2860

Q34255928-07B86509-E674-4834-BB37-42D64E29E2F6

Q34255928-12B5BB57-A7B2-430B-80C4-E17BE85246A8

Q34255928-21148A8C-F6C0-45A6-97BA-61EB2B78AFB9

Q34255928-28F910F0-2C33-4AE4-AEC4-903AF623FD40

Q34255928-2A3544D9-BB22-4180-8978-92C99347D8F1

Q34255928-34504521-8B1C-41C9-897B-C2C5ACFE75A6

Q34255928-574B2B38-20A1-41F6-A609-3FBE6C38E5DD

Q34255928-69E27C93-60B3-4A64-AE57-D685FBD9E829

Q34255928-6B65B398-32CF-4E47-A98C-390D707208C2

Q34255928-73E1089C-73BC-42F9-9D98-F90158F22EF0

P2888

Q34255928-E1CD3709-9193-486D-98C9-78F8B2E82AC7

P304

Q34255928-6334B350-48CE-4377-B988-9A9DCC162958

P31

Q34255928-4AFE6799-1A4D-41E7-A3B7-6DE8763A6640

P356

Q34255928-A0F2635C-C44D-46EE-8281-16ECE7552274

P407

Q34255928-69FAD99B-99C7-4B30-B786-31C272CE7545

P433

Q34255928-C0F652B5-BB48-407D-839B-497D8078B105

P478

Q34255928-C869DB31-817A-4980-8CB2-2BF7C6E8F4B2

P50

Q34255928-0F3F699B-6C33-4261-B29A-9ECC91B0A837

Q34255928-BEAB3A96-08CA-4214-A485-8765491B0B0B

P577

Q34255928-5EAB7E7C-FA63-458B-88C2-F26DE1A22586

P5875

Q34255928-B5317870-DCB6-4E2E-905D-563D946CB1BC

P6179

Q34255928-03A1239A-4D72-460C-B905-7C59A47F074E

P698

Q34255928-9A222364-8634-4E86-9DDF-F95D27D9AABF

P932

Q34255928-A63F5263-EB8B-470E-A346-1BF4BB32D643

P356

P1433

British Journal of Cancer

P1476

Melanoma sentinel node biopsy and prediction models for relapse and overall survival

@en

P2093

A Mitra

http://www.w3.org/2001/XMLSchema#string

B Powell

http://www.w3.org/2001/XMLSchema#string

C Conway

http://www.w3.org/2001/XMLSchema#string

C Walker

http://www.w3.org/2001/XMLSchema#string

F Elliott

http://www.w3.org/2001/XMLSchema#string

G Layer

http://www.w3.org/2001/XMLSchema#string

H Chong

http://www.w3.org/2001/XMLSchema#string

H Peach

http://www.w3.org/2001/XMLSchema#string

J A Newton-Bishop

http://www.w3.org/2001/XMLSchema#string

J H Barrett

http://www.w3.org/2001/XMLSchema#string

P2860

A new non-linear normalization method for reducing variability in DNA microarray experiments.

Osteopontin: role in cell signaling and cancer progression

Osteopontin: role in immune regulation and stress responses

Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome

Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues.

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.

Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients.

Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model.

Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas.

Sentinel-node biopsy or nodal observation in melanoma.

P2888

P304

1229-1236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6605849

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

Christian H. Ottensmeier

P577

2010-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46393669

http://www.w3.org/2001/XMLSchema#string

P6179

1026889634

http://www.w3.org/2001/XMLSchema#string

P698

20859289

http://www.w3.org/2001/XMLSchema#string

P932

2967048

http://www.w3.org/2001/XMLSchema#string